Bioavailability studies on para-aminosalicylic acid and its various salts in man. I. Absorption from solution and suspension

  • Suk Han Wan
  • Pertti Pentikainen
  • Daniel L. Azarnoff


The relative bioavailability of PAS and the sodium, potassium, and calcium salts of PAS has been studied. Absorption of PAS and its three salts is essentially complete. Dissolution of PAS appears to be a rate-limiting factor in its absorption. The type of salt administered affects the rate of absorption. Although absorption of all four compounds was complete, the areas under the plasma concentration-time curve, or bioavailable drug, are dependent on the rate of absorption. The data presented show evidence of rate-limited metabolism, especially in the first pass.

Key words

bioavailability PAS absorption first-pass effect 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    H. K. Fischer, R. H. Browning, R. L. Donnerberg, P. C. Pratt, and R. J. Atwell. Studies of conjugated PAS and ascorbic acid and other forms of para-aminosalicylic acid. II. Comparison of twenty-four-hour blood serum concentrations.Am. Rev. Tuberc. Pulm. Dis. 76: 880–887 (1957).Google Scholar
  2. 2.
    S. S. Cohen and W. Y. Yue. Toleration and absorption of phenyl para-aminosalicylate.Geriatrics 17: 715–723 (1962).PubMedGoogle Scholar
  3. 3.
    W. Y. Yue and S. S. Cohen. Toleration and absorption of sodium para-aminosalicylate and para-aminosalicylic acid (Neopasalate).Dis. Chest 49: 165–174 (1966).PubMedCrossRefGoogle Scholar
  4. 4.
    J. M. Schless, R. M. Inglis, J. H. Hammond, and J. M. Hale. Comparative evaluation of blood levels and tolerance of sodium PAS and conjugated PAS and ascorbic acid.Dis. Chest 50: 595–600 (1966).PubMedCrossRefGoogle Scholar
  5. 5.
    E. K. Marshall, Jr. Determination of para-aminosalicylic acid in blood.Proc. Soc. Exptl. Biol. Med. 68: 471–472 (1948).CrossRefGoogle Scholar
  6. 6.
    E. L. Way, P. K. Smith, D. L. Howie, R. Weiss, and R. Swanson. The absorption, distribution, excretion and fate of para-aminosalicylic acid.J. Pharmacol. Exptl. Therap. 93: 368–382 (1948).Google Scholar
  7. 7.
    J. Kawamata and K. Kashiwagi. Studies on the metabolism ofp-aminosalicylic acid. II. The fate of p-aminosalicylic acid in human body.Med. J. Osaka U. 6: 119–133 (1955).Google Scholar
  8. 8.
    R. G. Stoll, P. D. Holmes, S. B. Roth, and J. G. Wagner. A sensitive and specific method for the analysis of para-aminosalicylic acid and itsN-acetyl metabolite in human plasma.Res. Commun. Chem. Pathol. Pharmacol. 4: 327–338 (1972).PubMedCrossRefGoogle Scholar
  9. 9.
    H. Engeberg-Pedersen, P. Morch, and L. Tybring. Kinetics of serum aminosalicylic acid levels.Brit. J. Pharmacol. 23: 1–13 (1964).Google Scholar
  10. 10.
    J. Lehman. A micromethod for the determination of PAS in blood, urine and other biological fluids.Scand. J. Clin. Lab. Invest. 3: 306–310 (1951).CrossRefGoogle Scholar
  11. 11.
    H. Lauener, J. Hodler, G. Favez, E. Dettwiler, and L. Hadorn. Bildung und Ausscheidung der Stoffwechselprodukt vonp-Aminosalicylsaure.Klin. Wschr. 35: 393–401 (1957).PubMedCrossRefGoogle Scholar
  12. 12.
    J. G. Wagner and C. M. Metzler. Prediction of blood levels after multiple doses from single-dose blood level data: Data generated with two-compartment open model analyzed according to the one-compartment open model.J. Pharm. Sci. 58: 87–92 (1969).PubMedCrossRefGoogle Scholar
  13. 13.
    W. G. Cochran and G. M. Cox. InExperimental Designs, 2nd ed., Wiley, New York (1957), p. 111.Google Scholar
  14. 14.
    G. W. Snedecor and W. G. Cochran.Statistical Methods, 6th ed., The Iowa State University Press, Ames, Iowa (1967), pp. 560–561.Google Scholar
  15. 15.
    D. B. Duncan. Multiple range and multipleF tests.Biometrics 11: 1–42 (1955).CrossRefGoogle Scholar
  16. 16.
    M. M. Drucker, S. H. Blondheim, and L. Wislicki. Factors affecting acetylationin vivo of para-aminobenzoic acid in humans.Clin. Sci. 27: 133–141 (1964).PubMedGoogle Scholar
  17. 17.
    K. J. W. Hartiala and T. Terho. Metabolic acetylation by the mucosal membrane of the gastro-intestinal tract.Nature 205: 809–810 (1965).CrossRefGoogle Scholar
  18. 18.
    D. G. Shand and R. E. Rangno. The disposition of propranolol: Elimination during oral administration in man.Pharmacology 7: 159–168 (1972).PubMedCrossRefGoogle Scholar
  19. 19.
    D. Perrier and M. Gibaldi. Calculation of absorption rate constants for drugs with incomplete availability.J. Pharm. Sci. 62: 225–228 (1973).PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Publishing Corporation 1974

Authors and Affiliations

  • Suk Han Wan
    • 1
  • Pertti Pentikainen
    • 1
  • Daniel L. Azarnoff
    • 1
  1. 1.Clinical Pharmacology-Toxicology Center, Departments of Medicine and PharmacologyUniversity of Kansas Medical CenterKansas City

Personalised recommendations